Julio A. Urbina

Research.com Recognitions

• 1996 - Fellow of John Simon Guggenheim Memorial Foundation

Overview

Best Publications

• Specific chemotherapy of Chagas disease: controversies and advances.

  Julio A. Urbina;Roberto Docampo

  744
  Citations

• Specific chemotherapy of Chagas disease: relevance, current limitations and new approaches.

  Julio A. Urbina

  589
  Citations

• Chemotherapy of trypanosomiases and leishmaniasis

  Simon L. Croft;Michael P. Barrett;Julio A. Urbina

  506
  Citations

• Bisphosphonates inhibit the growth of Trypanosoma brucei, Trypanosoma cruzi, Leishmania donovani, Toxoplasma gondii, and Plasmodium falciparum: a potential route to chemotherapy.

  Michael B. Martin;Joshua S. Grimley;Jared C. Lewis;Huel T. Heath

  421
  Citations

• Molecular order and dynamics of phosphatidylcholine bilayer membranes in the presence of cholesterol, ergosterol and lanosterol: a comparative study using 2H-, 13C- and 31p-NMR spectroscopy

  Julio A. Urbina;Sara Pekerar;Hong biao Le;Jessica Patterson

  333
  Citations

• Chemotherapy of Chagas disease.

  Julio A. Urbina

  301
  Citations

• The challenges of Chagas Disease-- grim outlook or glimmer of hope.

  Rick L Tarleton;Richard Reithinger;Julio A Urbina;Uriel Kitron

  294
  Citations

• Ergosterol biosynthesis and drug development for Chagas disease.

  Julio A Urbina

  287
  Citations

• Activities of the triazole derivative SCH 56592 (posaconazole) against drug-resistant strains of the protozoan parasite Trypanosoma (Schizotrypanum) cruzi in immunocompetent and immunosuppressed murine hosts.

  Judith Molina;Olindo Martins-Filho;Zigman Brener;Alvaro J. Romanha

  254
  Citations

• Cure of Short- and Long-Term Experimental Chagas' Disease Using D0870

  Julio A. Urbina;Gilberto Payares;Judith Molina;Cristina Sanoja

  252
  Citations

• Lipid biosynthesis pathways as chemotherapeutic targets in kinetoplastid parasites.

  Urbina Ja

  242
  Citations

• Toward a Novel Metal-Based Chemotherapy against Tropical Diseases. 2. Synthesis and Antimalarial Activity in Vitro and in Vivo of New Ruthenium− and Rhodium−Chloroquine Complexes

  Roberto A. Sánchez-Delgado;Maribel Navarro;Hilda Pérez;Julio A. Urbina

  235
  Citations

• Amiodarone has intrinsic anti-Trypanosoma cruzi activity and acts synergistically with posaconazole.

  Gustavo Benaim;John M. Sanders;Yael Garcia-Marchán;Claudia Colina

  231
  Citations

• Venezuela's humanitarian crisis, resurgence of vector-borne diseases, and implications for spillover in the region

  Maria E Grillet;Juan V Hernández-Villena;Martin S Llewellyn;Alberto E Paniz-Mondolfi

  222
  Citations

• In vitro and in vivo activities of ravuconazole on Trypanosoma cruzi, the causative agent of Chagas disease.

  Julio A Urbina;Gilberto Payares;Cristina Sanoja;Renee Lira

  217
  Citations

• Antiproliferative effects and mechanism of action of SCH 56592 against Trypanosoma (Schizotrypanum) cruzi: in vitro and in vivo studies.

  Julio A. Urbina;Gilberto Payares;Lellys M. Contreras;Andreína Liendo

  210
  Citations

• Recent Clinical Trials for the Etiological Treatment of Chronic Chagas Disease: Advances, Challenges and Perspectives

  Julio A. Urbina

  199
  Citations

• Trypanosoma cruzi contains major pyrophosphate stores, and its growth in vitro and in vivo is blocked by pyrophosphate analogs.

  Julio A. Urbina;Benjamin Moreno;Stephanie Vierkotter;Eric Oldfield

  190
  Citations

• Successful Treatment with Posaconazole of a Patient with Chronic Chagas Disease and Systemic Lupus Erythematosus

  María-Jesús Pinazo;Gerard Espinosa;Montserrat Gállego;Paulo Luis López-Chejade

  183
  Citations

• Ultrastructural alterations induced by two ergosterol biosynthesis inhibitors, ketoconazole and terbinafine, on epimastigotes and amastigotes of Trypanosoma (Schizotrypanum) cruzi.

  K Lazardi;J A Urbina;W de Souza

  173
  Citations